The present invention describes pharmaceutical combinations, compositions, and methods comprising a statin and 6-propylamino-4, 5, 6, 7-tetrahydro-1, 3- benzothiazole-2-amine or a pharmaceutically acceptable salt and/or solvate thereof, 5 that are useful for the treatment of synucleinopathic disorders.